CD4 and Cowden disease: We investigated whether the new synthesized DQ2.5 heterodimer, expressed following APC transfection, was able to stimulate a CD4+ T-cell line, previously established from the intestinal biopsies of a homozygous DR3/DR3 CD patient [14].